Form 4: HealthEquity Director Acquires Shares

Evelyn S. Dilsaver, a Director at HealthEquity, Inc., acquired 2,877 shares of common stock on June 25, 2026.

Summary

• Evelyn S. Dilsaver, a Director at HealthEquity, Inc. (HQY), acquired 2,877 shares of common stock on June 25, 2026.
• This acquisition resulted in Dilsaver beneficially owning 51,085 shares of common stock.
• The transaction was recorded as a purchase with a price of $0, indicating it was likely an award or grant.
• Additionally, Dilsaver holds two stock options: one immediately exercisable with a strike price of $50.41, and another with a strike price of $66.06.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider stock acquisitions can be positive, the $0 acquisition price suggests an award rather than a market purchase, and the filing is purely transactional without broader company performance updates.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 2,877 shares by a director is a direct investment in the company.

Negatives

• The acquisition price of $0 suggests these shares were awarded rather than purchased on the open market, which may not reflect a market-driven investment decision.

Risks

• The filing does not explicitly detail risks associated with this specific transaction.
• However, general risks associated with stock ownership, such as market volatility and potential decline in share price, are inherent.

Future Outlook

The filing itself is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding the company's financial performance. The details on restricted stock units and stock options suggest future potential equity value for the reporting person.

Management Comments

• The filing incorporates by reference a Power of Attorney previously filed on June 26, 2023, for Michael Newton to act as Attorney-in-Fact for Ms. Dilsaver.

Industry Context

StockSavvy.ai notes that insider transactions, such as this Form 4 filing by a director, are closely watched by the market as potential indicators of management's confidence in the company's performance and future prospects within the health savings account and benefits administration industry.

Stakeholder Impact

• Shareholders: The acquisition by a director may be interpreted as a positive signal of confidence, potentially influencing investor sentiment.
• Management: Reinforces the alignment of interests between management and shareholders through equity ownership.

Next Steps

• Vesting of restricted stock units on or before June 25, 2027.
• Potential exercise of stock options as they become exercisable.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Stock Acquisition, Director, Securities, SEC Filing